REST protects dopaminergic neurons from mitochondrial and α-synuclein oligomer pathology in an alpha synuclein overexpressing BAC-transgenic mouse model

REST protects dopaminergic neurons from mitochondrial and α-synuclein oligomer pathology in an alpha synuclein overexpressing BAC-transgenic mouse model

Alpha-synuclein pathology is associated with dopaminergic neuronal loss in the substantia nigra (SN) of Parkinson's patients. Working across human and mouse models, we investigated mechanisms by which the accumulation of soluble α-synuclein oligomers leads to neurodegeneration. Bioche...

Full description

Bibliographic Details
Main Authors:	Ryan, BJ, Bengoa-Vergniory, N, Williamson, M, Kirkiz, E, Roberts, R, Corda, G, Sloan, M, Saqlain, S, Cherubini, M, Poppinga, J, Bogtofte, H, Cioroch, M, Hester, S, Wade-Martins, R
Format:	Journal article
Language:	English
Published:	Society for Neuroscience 2021

Similar Items

Alpha-synuclein proximity ligation assay (AS-PLA) in brain sections to probe for alpha-synuclein oligomers
by: Roberts, RF, et al.
Published: (2019)

Alpha-synuclein oligomers: a new hope.
by: Bengoa-Vergniory, N, et al.
Published: (2017)

Targeting alpha-synuclein as a therapy for Parkinson’s disease
by: Fields, CR, et al.
Published: (2019)

Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo.
by: Periquet, M, et al.
Published: (2007)

Loss of microRNA-7 regulation leads to α-synuclein accumulation and dopaminergic neuronal loss in vivo
by: McMillan, K, et al.
Published: (2017)

The role of alpha-synuclein oligomers in Parkinson's disease pathophysiology and biology
by: Roberts, R
Published: (2015)

Molecular and behavioural characterisation of novel alpha-synuclein BAC transgenic mouse models of Parkinson's disease
by: Janezic, S
Published: (2013)

Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse.
by: Taylor, T, et al.
Published: (2014)

Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity
by: Brekk, OR, et al.
Published: (2020)

Endogenous alpha-synuclein influences the number of dopaminergic neurons in mouse substantia nigra.
by: Garcia-Reitboeck, P, et al.
Published: (2013)

Studying α-Synuclein pathology using iPSC-derived dopaminergic neurons
by: Zambon, F
Published: (2017)

Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles
by: Doucet, M, et al.
Published: (2017)

Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons
by: Zambon, F, et al.
Published: (2019)

α-Synuclein and mitochondrial bioenergetics regulate tetrahydrobiopterin levels in a human dopaminergic model of Parkinson disease.
by: Ryan, B, et al.
Published: (2014)

The effect of truncated human alpha-synuclein (1-120) on dopaminergic cells in a transgenic mouse model of Parkinson's disease.
by: Michell, A, et al.
Published: (2007)

Striatal dopamine transporter function is facilitated by converging biology of α-synuclein and cholesterol
by: Threlfell, S, et al.
Published: (2021)

Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson's disease
by: Ruffmann, C, et al.
Published: (2018)

Assessment of α-Synuclein Pathology
by: Alafuzoff, I, et al.
Published: (2008)

Green tea catechin, EGCG, modulates mitochondrial dynamics in dopaminergic neurons of α-synuclein transgenic flies resulting in mobility improvement.
by: Choo, Wen Rui.
Published: (2012)

Striatal dopamine transmission is subtly modified in human A53T(Alpha)-synuclein overexpressing mice.
by: Platt, N, et al.
Published: (2012)

Explaining the Structural Plasticity of α-Synuclein
by: Ullman, Orly, et al.
Published: (2012)

Physiological and pathological properties of alpha-synuclein.
by: Tofaris, G, et al.
Published: (2007)

The Transcellular Propagation and Intracellular Trafficking of α-Synuclein
by: Tofaris, GK, et al.
Published: (2016)

How is alpha‐synuclein cleared from the cell?
by: Stefanis, L, et al.
Published: (2019)

Phenotypic manifestation of α-synuclein strains derived from Parkinson’s disease and multiple system atrophy in human dopaminergic neurons
by: Tofaris, GK, et al.
Published: (2021)

Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein.
by: Senior, S, et al.
Published: (2008)

Alpha-synuclein pathology in the olfactory pathways of dementia patients.
by: Hubbard, P, et al.
Published: (2007)

α-Synuclein and dopamine at the crossroads of Parkinson's disease.
by: Venda, L, et al.
Published: (2010)

Monitoring α-synuclein proteotoxicity in Drosophila models
by: Szabo, A, et al.
Published: (2019)

Alpha-synuclein dysfunction in Lewy body diseases.
by: Tofaris, G, et al.
Published: (2005)

Alpha-synuclein pathology in the olfactory pathways of patients with dementia
by: Hubbard, P, et al.
Published: (2006)

Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.
by: Tofaris, G, et al.
Published: (2006)

RNA interference-mediated knockdown of alpha-synuclein protects human dopaminergic neuroblastoma cells from MPP(+) toxicity and reduces dopamine transport.
by: Fountaine, T, et al.
Published: (2007)

Initiation and progression of α-synuclein pathology in Parkinson’s disease
by: Tofaris, GK
Published: (2022)

Modelling of the microglial response to neuronal α-synuclein aggregation
by: Katsikoudi, A
Published: (2022)

Stem cell modelling of ⍺-synuclein aggregation and its pathology
by: Tanudjojo, B
Published: (2021)

Prolongation of metallothionein induction combats Aß and α-synuclein toxicity in aged transgenic Caenorhabditis elegans
by: Pretsch, D, et al.
Published: (2020)

The role of non-coding regions of the alpha-synuclein gene in protein expression and the determination of alternatively spliced alpha-synuclein isoforms in oxidatively stressed cells
by: Williams, SE
Published: (2013)

CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease
by: Bengoa-Vergniory, N, et al.
Published: (2020)

Widespread and abundant α-synuclein pathology in a neurologically unimpaired subject
by: Parkkinen, L, et al.
Published: (2005)